Drug class in one race
GLP-1 receptor drugs for Obesity
35 tracked GLP-1 receptor drugs in the Obesity race. The class explanation lives on the GLP-1 receptor page; the full indication pipeline across every mechanism is on the Obesity page.
3 approved / phase 419 Phase 31 Phase 2/37 Phase 21 Phase 1/24 Phase 1
Head-to-head evidence: ASC30 vs BMF-650 · ASC30 vs CT-996 · ASC30 vs CX11 · ASC30 vs DA-302168S · ASC30 vs DD01 · ASC30 vs DWRX5003